|
|
|
|
 |
| October 28,
2010 | ISSUE NUMBER 172 VOL 8 |
Ethics
Pharma Gets the ProPublica Treatment
Alternative news organization and media allies investigate the industry’s payments to doctors—launching a fresh assault on the ethical status quo.
Drug Safety
Understanding Serious Adverse Events Requires Serious Cooperation
What if the technology is at hand to prevent adverse reactions to medicines before they start?
Emerging Markets
Brazil Repositions for Pharma Growth
Brazil claims a bright future as a drug research and clinical trials site—but IP issues continue to raise concerns among the multinational investor community.
Technology
Roche’s New Social Media Guidelines
The Swiss drug maker’s new guidelines for staff behavior online—personal and professional—have been broadly welcomed. But do they go too far, or not far enough?
|
|
 // Healthcare agency dDFCB appointed Martin Laiks as EVP, Managing Director. Martin was most recently Managing Director at the Health and Wellness Practice of G2 (Grey Group) in New York. //Shire appointed Philip Vickers as Senior VP of research and development for its Human Genetic Therapies (HGT) business.//eClinical Solutions’ Executive Vice President Susan Bornstein was named a finalist in the 7th Annual Stevie Awards for Women in Business. // Lisa Blair, founder of The Hobart Group (New Jersey), a healthcare/pharma communications company, was named one of Ernst & Young’s Entrepreneurial Winning Women 2010.// |
|
|
|
|
|
Nov 4: SharePoint User Workshop for the Life Sciences Industry
Princeton, NJ
Nov 16–18: Risk-Based Decision Making
Burlingame, CA
Dec 5–7: Clinic 2010 Symposium: Achieving the Vision — Advancing High-Value Health Care
Bethesda, MD
Dec 8–9: CMAC 2010 – Commercialization and Market Access Congress
Orlando, FL |
|
 |
|
|
|
CBI’s 8th Pharmaceutical Compliance Congress — January 24-25, 2011, Washington, DC
Hear from a dozen CCOs and esteemed compliance, legal and regulatory executives from Boehringer, Cephalon, Daiichi, DDMAC, DOJ, Eisai, Endo, GSK, J&J, Lilly, Novo Nordisk, Pfizer, sanofi-aventis, UCB, U.S. Attorney’s Office and more. Thousands have benefited - Don’t miss the compliance event of the year! Register today at
www.cbinet.com/pcc. |
CBI’s Commercialization and Market Access Congress (CMAC 2010) — 12/8-12/9, Orlando, FL.
The event of the year! CMAC combines a strategic view of early-stage and launch planning with targeted programming and extensive coverage of the evolving dynamics of market access. 30+ experts from AstraZeneca, Cephalon, Daiichi, Medtronic, Mannkind, Merck, Pfizer and more! Register at www.cmac2010.com by 11/12 and save $400 with code FET959. |
Mayo Clinic:
Help shape health care of the future! Register now to attend the 2010 Mayo Clinic Health Policy Center Symposium “Achieving the Vision: Advancing High-Value Health Care," December 5-7, 2010, in Bethesda, Maryland.
The Symposium will determine key priorities that will further the evolution to a high-value health system. Join with national leaders to build consensus on the future of high-value health care delivery.
For more information: www.mayoclinic.org/healthpolicycenter/ |
|
PE House:
Watch the new pharma interview show: PHARMA FACEOFF
Expert insights delivered to your desktop or mobile device. Features the best in biopharma debating today’s most pressing issues.
Rate the episode, share or like us on Facebook, post it on your site. Hosted by Barbara Ryan, pharmaceutical analyst from Deutsche Bank. A presentation of Pharmaceutical Executive.
WATCH ONE MINUTE PREVIEW |
Take the Safe Path to creating ERP Value.
You simply cannot afford to handle the complexities of chargebacks, scalability, and compliance with ERP “solutions” that don’t add value to your bottom line. Moving forward with a new solution? Learn how to avoid the pitfalls, and manage risk, during all stages of an ERP project, so that you can enjoy the payoffs quickly and (relatively) painlessly.
www.cbinet.com |
| |
|
|
|
|
 |
|
 |
|
 |
| Where do you see technology making the biggest impact in pharma in the next few years? |
|
|
| |
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
